{"task_id": "a2647f7b1bf36671", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 400/464)", "text": "ENT ISSUES (CONT\u2019D)\nPrinciples of Pain Control\n393\n\n--- Page 415 ---\nDelirium\nSee DELIRIUM (p. 380)\nCancer-Related Fatigue\nCAUSES\nALTERED PHYSIOLOGY\ncytokine dysregulation,\nserotonin neurotransmitter dysregulation, HPA axis\ndysfunction, circadian rhythm disruption, vagal\nafferent activation, alterations in muscle ATP\nmetabolism\nCONTRIBUTING FACTORS wASTHENICw\n\u0002 ANEMIA, ANOREXIA\n\u0002 SLEEP DISTURBANCES, SHORTNESS OF BREATH\n\u0002 THROBBING PAIN\n\u0002 HEAD\ndepression, anxiety\n\u0002 ELECTROLYTES\nNa, K, Mg, Ca\n\u0002 NUTRITIONAL FAILURE\nanorexia cachexia\n\u0002 INACTIVITY\n\u0002 COMORBIDITIES\ncardiac/pulmonary failure, hepa\ntic/renal failure, neurologic/endocrine failure such\nas hypothyroidism, hypogonadism, adrenal insuffi\nciency, infections\nPATHOPHYSIOLOGY\nDEFINITION\na\ndistressing,\npersistent,\nsubjective\nsense of tiredness or exhaustion related to cancer or\ncancer treatment that interferes with usual functioning.\nCancer related fatigue is distinct from everyday tired\nness as it does not correspond to the patient\u2019s level of\nexertion and is not typically relieved by rest or sleep.\nNote that fatigue has not been well studied in other\npalliative care settings, although the underlying patho\nphysiology and treatments are similar to cancer related\nfatigue\nPATHOPHYSIOLOGY (CONT\u2019D)\nPREVALENCE\ncancer related fatigue is essentially\npresent throughout the cancer journey, including\n40% at diagnosis, 80 90% during cancer treatment,\n30% 1 year post treatment, 75% with metastatic dis\nease, and >90% at the end of life. It is also under\ndiagnosed and under treated\nCLINICAL FEATURES\nSCREENING\n\u2018\u2018How would you rate your fatigue on a\nscale of 0 10 over the past 7 days?\u2019\u2019\n0\nAbsence of fatigue\n1 3\nMild fatigue\n4 6\nModerate fatigue\n7 10\nSevere fatigue\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, glucose, TSH, Mg,\nCa, albumin\nMANAGEMENT\nNON PHARMACOLOGIC\nexercise\nfor\nat\nleast\n30 min/day (strongest evidence), psychosocial inter\nventions, nutritional counseling, sleep therapy\nPHARMACOLOGIC\nmethylphenidate 5 mg PO qAM\nand noon, and 5 mg q4h PO PRN, up to 20 mg/day;\nmodafinil 200 mg PO daily, corticosteroids (dexa\nmethasone 4 mg PO BID)\nDyspnea in the Palliative Setting\nDIFFERENTIAL DIAGNOSIS OF ACUTE DYSPNEA\nRESPIRATORY\n\u0002\nPARENCHYMA\npneumonia, ARDS, lymphangitic\ncarcinomatosis, lung cancer\n\u0002\nAIRWAY\nCOPD exacerbation, asthma exacerba\ntion, acute bronchitis, bronchiectasis, obstruction\n(cancer)\n\u0002\nVASCULAR\npulmonary\nembolism,\npulmonary\nhypertension, SVC obstruction\n\u0002\nPLEURAL\npleural effusion, pneumothorax\nDIFFERENTIALDIAGNOSISOFACUTEDYSPNEA(CONT\u2019D)\nCARDIAC\n\u0002\nMYOCARDIAL\nHF\nexacerbation,\nmyocardial\ninfarction\n\u0002\nVALVULAR\naortic stenosis, acute aortic regurgi\ntation, endocarditis\n\u0002\nPERICARDIAL\npericardial effusion, tamponade\nSYSTEMIC\nsepsis, metabolic acidosis, anemia\nOTHERS\nneuromuscular\n(cachexia),\nanxiety,\ntense ascites\n394\nDyspnea in the Palliative Setting", "text_length": 2849, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 400/464)", "type": "chunk", "chunk_index": 399, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.799607", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.800352", "status": "pending"}